ShockWave Medical (SWAV) Revenue & Revenue Breakdown


OverviewForecastOwnershipFinancialsChartTranscripts

ShockWave Medical Revenue Highlights


Latest Revenue (Y)

$730.23M

Latest Revenue (Q)

$218.81M

Main Segment (Y)

Coronary

Main Geography (Y)

UNITED STATES

ShockWave Medical Revenue by Period


ShockWave Medical Revenue by Year

DateRevenueChange
2023-12-31$730.23M49.11%
2022-12-31$489.73M106.51%
2021-12-31$237.15M249.83%
2020-12-31$67.79M57.92%
2019-12-31$42.93M250.05%
2018-12-31$12.26M613.38%
2017-12-31$1.72M-

ShockWave Medical generated $730.23M in revenue during NA 2023, up 49.11% compared to the previous quarter, and up 5954.74% compared to the same period a year ago.

ShockWave Medical Revenue by Quarter

DateRevenueChange
2024-03-31$218.81M7.80%
2023-12-31$202.98M9.12%
2023-09-30$186.02M3.25%
2023-06-30$180.16M11.86%
2023-03-31$161.07M11.83%
2022-12-31$144.03M9.67%
2022-09-30$131.33M8.77%
2022-06-30$120.75M28.96%
2022-03-31$93.63M11.22%
2021-12-31$84.18M29.20%
2021-09-30$65.16M16.54%
2021-06-30$55.91M75.26%
2021-03-31$31.90M40.43%
2020-12-31$22.72M15.96%
2020-09-30$19.59M90.45%
2020-06-30$10.29M-32.32%
2020-03-31$15.20M6.18%
2019-12-31$14.31M26.29%
2019-09-30$11.33M13.19%
2019-06-30$10.01M37.74%
2019-03-31$7.27M43.60%
2018-12-31$5.06M40.61%
2018-09-30$3.60M57.96%
2018-06-30$2.28M72.39%
2018-03-31$1.32M-

ShockWave Medical generated $218.81M in revenue during Q1 2024, up 7.80% compared to the previous quarter, and up 151.92% compared to the same period a year ago.

ShockWave Medical Revenue Breakdown


ShockWave Medical Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 23Dec 22Dec 21Dec 20
Other Product Line$2.67M$3.59M$1.62M$1.21M
Peripheral$194.35M$132.28M$74.06M$41.99M
Coronary$528.85M$353.86M$161.46M$24.59M

ShockWave Medical's latest annual revenue breakdown by segment (product or service), as of Dec 23: Coronary (72.86%), Peripheral (26.77%), and Other Product Line (0.37%).

Quarterly Revenue by Product

Product/ServiceMar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21
Peripheral$51.84M$48.12M$47.84M$52.26M$46.13M$40.50M$37.05M$31.89M$22.85M$21.41M$17.73M$18.79M$16.14M
Product and Service, Other$599.00K$572.00K$895.00K$1.06M$1.24M$1.03M$442.00K------
Coronary$164.53M$152.87M$136.32M$125.78M$113.88M$102.65M$93.04M$87.83M$70.34M$62.29M$47.16M$36.70M$15.31M
Other Product Line---------$490.00K$265.00K$413.00K$451.00K

ShockWave Medical's latest quarterly revenue breakdown by segment (product or service), as of Mar 24: Coronary (75.83%), Peripheral (23.89%), and Product and Service, Other (0.28%).

ShockWave Medical Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 23Dec 22Dec 21Dec 20Dec 19
UNITED STATES$581.55M$407.43M$186.32M$37.12M$22.70M
All Other Countries$71.17M$31.30M$12.25M$7.21M$2.73M
Europe$77.52M$51.01M$38.57M--
Rest Of Europe---$19.14M$14.10M
GERMANY---$4.31M$3.40M

ShockWave Medical's latest annual revenue breakdown by geography, as of Dec 23: UNITED STATES (79.64%), Europe (10.62%), and All Other Countries (9.75%).

Quarterly Revenue by Country

CountryMar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19Jun 19
Europe$26.26M$23.01M$19.35M$18.91M$16.23M$13.79M$11.76M$13.39M$12.07M$11.30M$8.62M$10.42M--------
All Other Countries$17.01M$21.88M$19.77M$16.31M$13.21M$11.93M$9.07M$7.26M$3.04M$3.28M$3.76M$2.58M$2.63M$3.32M$1.67M$817.00K$1.41M$1.03M$786.00K$658.00K
UNITED STATES$175.53M$158.09M$146.90M$144.94M$131.62M$118.31M$110.50M$100.10M$78.52M$69.59M$42.91M$21.05M$12.67M$11.14M$5.54M$7.77M$7.64M$6.25M$5.17M-
U S----------$52.77M---------
Rest Of Europe------------$6.91M$5.33M$5.59M$3.11M$5.11M$4.62M$3.43M$3.31M
GERMANY------------$1.31M$1.39M$1.19M$825.00K$911.00K$1.01M$873.00K$873.00K

ShockWave Medical's latest quarterly revenue breakdown by geography, as of Mar 24: UNITED STATES (80.22%), Europe (12.00%), and All Other Countries (7.77%).

ShockWave Medical Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
SYKStryker$20.50B$5.49B
EWEdwards Lifesciences$6.00B$1.39B
ALGNAlign$3.86B$1.03B
DXCMDexCom$3.62B$994.20M
MASIMasimo$2.05B$492.80M
PODDInsulet$1.70B$488.50M
PENPenumbra$1.06B$301.04M
TNDMTandem Diabetes Care$747.72M$331.03M
SWAVShockWave Medical$730.23M$218.81M
INSPInspire Medical Systems$624.80M$195.88M
NARIInari Medical$493.63M$153.39M
TMDXTransMedics Group$241.62M$-12.24M
OMOutset Medical$130.38M$27.39M
CLPTClearPoint Neuro$23.95M$7.86M

SWAV Revenue FAQ


ShockWave Medical's yearly revenue for 2023 was $730.23M, representing an increase of 49.11% compared to 2022. The company's yearly revenue for 2022 was $489.73M, representing an increase of 106.51% compared to 2021. SWAV's yearly revenue for 2021 was $237.15M, representing an increase of 249.83% compared to 2020.

ShockWave Medical's quarterly revenue for Q1 2024 was $218.8M, a 7.80% increase from the previous quarter (Q4 2023), and a 35.85% increase year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $202.98M, a 9.12% increase from the previous quarter (Q3 2023), and a 40.93% increase year-over-year (Q4 2022). SWAV's quarterly revenue for Q3 2023 was $186.02M, a 3.25% increase from the previous quarter (Q2 2023), and a 41.64% increase year-over-year (Q3 2022).

ShockWave Medical's revenue growth rate for the last 3 years (2021-2023) was 207.92%, and for the last 5 years (2019-2023) was 1601.10%.

ShockWave Medical's revenue streams in c 23 are Other Product Line, Peripheral, and Coronary. Other Product Line generated $2.67M in revenue, accounting 0.37% of the company's total revenue, down -25.60% year-over-year. Peripheral generated $194.35M in revenue, accounting 26.77% of the company's total revenue, up 46.92% year-over-year. Coronary generated $528.84M in revenue, accounting 72.86% of the company's total revenue, up 49.45% year-over-year.

For the fiscal year ending Dec 23, the largest source of revenue of ShockWave Medical was Coronary. This segment made a revenue of $528.84M, representing 72.86% of the company's total revenue.